Tofacitinib ameliorates Campylobacter-induced intestinal pathology by suppressing IFNγ producing ILCs and T cells
托法替尼通过抑制产生 IFNγ 的 ILC 和 T 细胞来改善弯曲杆菌引起的肠道病理。
期刊:Mucosal Immunology
影响因子:7.6
doi:10.1016/j.mucimm.2025.06.010
Korchagina, Anna A; Shein, Sergey A; Muraoka, Wayne T; Nguyen, Justin; Chen, Qiangxing; Tumanova, Anna A; Todd, Austin W; Rivera, Carlos E; Tamayo, Rita; Casali, Paolo; Koroleva, Ekaterina; Tumanov, Alexei V